Ivan C. Ho

Ivan C. Ho

Auto-generated profile, based on publicly available information

Ivan C. Ho

Department of Cardiology, Good Samaritan Hospital, 1225 Wilshire Boulevard, Third floor, Los Angeles, CA 90017, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2014 in EP Europace
Verified
Journal Article
Open access
PDF file
YMYosuke Miwa
Yosuke Miwa
HMHitoshi Minamiguchi
Hitoshi Minamiguchi
ABAnil K. Bhandari
Anil K. Bhandari
DCDavid S. Cannom
David S. Cannom
IHIvan C. Ho
Ivan C. Ho
The step-wise approach to catheter ablation for persistent atrial fibrillation (AF) requires considerable substrate modification targeting at complex fractionated atrial electrograms (CFAEs) in addition to pulmonary vein (PV) isolation. An alternative strategy that minimizes the amount of ablation would be desirable. The aim of this study was to investigate whether the use of pre-procedural amiodarone affects: (i) the amount of ablation required to achieve procedural success, and (ii) long-term outcomes. We studied 121 consecutive patients with persistent AF who underwent catheter ablation. The patients were divided into two groups: Group 1, amiodarone (n = 31); Group 2, other antiarrhythmic drugs or rate control (n = 90). All the patients underwent a step-wise ablation procedure beginning with PV isolation, then proceeding with ablation of the CFAEs and linear lesions until sinus rhythm was achieved. Mean left atrial cycle length of AF (AFCL) was recorded at each step. The number of CFAE ablation sites was recorded. The number of CFAE sites in Group 1 was significantly less than that in Group 2 (P = 0.0121). The AFCLs after each step in Group 1 were significantly longer than those in Group 2. The procedure time and the radiofrequency time of CFAE ablation in Group 1 were significantly shorter than that in Group 2 (P = 0.0276 and P = 0.0458, respectively). There was no significant difference between the two groups in early and long-term outcomes. Use of pre-procedural amiodarone prolongs AFCL during catheter ablation and reduces the number of CFAE sites requiring ablation to achieve procedural success while maintaining equivalent long-term results.

16 December 2010 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
AZAndrew A. Zadeh
Andrew A. Zadeh
DCDavid S. Cannom
David S. Cannom
BMBruce L. Macrum
Bruce L. Macrum
IHIvan C. Ho
Ivan C. Ho